Loading organizations...
The SpringHill Company operates as a global consumer and entertainment brand, specializing in the development and production of culturally relevant content. It builds and creates compelling stories across various mediums, including television, feature films, and digital platforms, emphasizing narratives that resonate with diverse audiences. The company provides a range of offerings from web series to short films, consistently focusing on impactful storytelling.
This enterprise was founded by LeBron James and Maverick Carter in 2020, consolidating their prior ventures under a unified banner. The duo’s insight centered on empowering individuals through content and creating a platform for authentic, culturally-driven narratives. Both founders brought significant experience from the sports and entertainment industries, leveraging their understanding of audience engagement and content strategy.
The company primarily serves a broad, cross-cultural audience, alongside creators and media partners seeking to produce influential content. Its overarching mission is to empower greatness in every individual, aspiring to inspire and ignite cultural movements. The SpringHill Company envisions a future where its creations foster significant social impact and resonate globally.
Key people at Springhill.
Springhill was founded in 2020 by LeBron James (Founder).
Springhill was founded in 2020 by LeBron James (Founder).
Springhill has 2 tracked investments across 2 companies. The latest tracked deal is $231.5M Series F in Beijing Yuan Xin in August 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 12, 2021 | Beijing Yuan Xin | $231.5M Series F | — | AB Initio Capital, B Capital Group, CITIC Securities, Future Innovation, HEL VED, Stella Zhou, Index Capital, Kunling Capital, OrbiMed, Sequoia Capital, UOB |
| Aug 3, 2021 | Yuanxin Huibao | $232.1M Series F | — | B Capital Group, CITIC Securities, HEL VED, Hongshan Capital Group (Sequoia Capital China), INCE Capital, Kunling Capital, OrbiMed, UOB |